Cardiovascular outcome in critically ill patients treated with continuous haemofiltration--beneficial effects of bicarbonate-buffered replacement fluids.
Barenbrock
Michael
M
Department of Medicine, University of Münster, Germany.
Schaefer
Roland M
RM
D058186:Acute Kidney Injury / Q000150:complications / Q000378:metabolism / Q000401:mortality / Q000628:therapy*; D001639:Bicarbonates / Q000627:therapeutic use*; D002021:Buffers; D002318:Cardiovascular Diseases / Q000209:etiology* / Q000401:mortality / Q000517:prevention & control; D003404:Creatinine / Q000097:blood; D016638:Critical Illness; D015314:Dialysis Solutions / Q000627:therapeutic use*; D006440:Hemofiltration / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D015994:Incidence; D019344:Lactic Acid / Q000097:blood / Q000627:therapeutic use; D016015:Logistic Models; D016896:Treatment Outcome
D001639:Bicarbonates; D002021:Buffers; D015314:Dialysis Solutions; D019344:Lactic Acid; D003404:Creatinine